Milton Packer

11.6k total citations · 4 hit papers
94 papers, 8.8k citations indexed

About

Milton Packer is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Milton Packer has authored 94 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Cardiology and Cardiovascular Medicine, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in Milton Packer's work include Heart Failure Treatment and Management (45 papers), Cardiovascular Function and Risk Factors (19 papers) and Cardiac electrophysiology and arrhythmias (10 papers). Milton Packer is often cited by papers focused on Heart Failure Treatment and Management (45 papers), Cardiovascular Function and Risk Factors (19 papers) and Cardiac electrophysiology and arrhythmias (10 papers). Milton Packer collaborates with scholars based in United States, United Kingdom and France. Milton Packer's co-authors include Beth Levine, Andrew J.S. Coats, Michael B. Fowler, Noboru Mizushima, Xiao Huan Liang, Michael Schneider, Amina Tassa, Xueping Qu, Sophie Pattingre and Rita Garuti and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

Milton Packer

83 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy

2005 2.9k citations Milton Packer et al. profile →
Effect of carvedilol on survival in severe chronic heart failure

2001 1.3k citations Milton Packer, Michael B. Fowler et al. profile →
Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis

2012 907 citations Milton Packer et al. profile →
Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis

2014 421 citations Hajime Uno, Brian Claggett et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Milton Packer United States	29	3.6k	3.5k	2.3k	841	792	94	8.8k
Sebastiano Sciarretta Italy	50	2.7k 0.8×	3.0k 0.9×	4.2k 1.9×	1.1k 1.3×	1.4k 1.8×	214	10.0k
Anirban Banerjee United States	60	1.7k 0.5×	1.7k 0.5×	2.7k 1.2×	2.0k 2.4×	1.2k 1.6×	288	13.2k
Masatsugu Hori Japan	53	1.0k 0.3×	3.6k 1.0×	2.0k 0.9×	1.7k 2.0×	678 0.9×	197	8.2k
Stefan Frantz Germany	56	1.3k 0.4×	6.6k 1.9×	4.2k 1.9×	2.1k 2.5×	1.1k 1.3×	269	12.3k
Jane E. Freedman United States	54	983 0.3×	2.2k 0.6×	3.3k 1.5×	1.0k 1.2×	1.5k 1.8×	175	10.2k
Zhengyuan Xia China	50	897 0.3×	1.5k 0.4×	3.2k 1.4×	1.1k 1.3×	1.2k 1.5×	275	8.9k
Douglas E. Vaughan United States	70	2.0k 0.6×	6.5k 1.9×	4.0k 1.8×	2.9k 3.4×	1.9k 2.4×	229	17.0k
Giuseppe Danilo Norata Italy	57	2.0k 0.6×	1.8k 0.5×	2.7k 1.2×	3.0k 3.6×	956 1.2×	235	10.5k
Carol Forsblom Finland	60	1.7k 0.5×	2.2k 0.6×	2.4k 1.1×	2.5k 2.9×	1.7k 2.1×	276	12.2k
Kari Pulkki Finland	47	1.2k 0.3×	2.6k 0.8×	2.0k 0.9×	1.2k 1.5×	747 0.9×	206	8.0k

Countries citing papers authored by Milton Packer

Since Specialization

Citations

This map shows the geographic impact of Milton Packer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milton Packer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milton Packer more than expected).

Fields of papers citing papers by Milton Packer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milton Packer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milton Packer. The network helps show where Milton Packer may publish in the future.

Co-authorship network of co-authors of Milton Packer

This figure shows the co-authorship network connecting the top 25 collaborators of Milton Packer. A scholar is included among the top collaborators of Milton Packer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milton Packer. Milton Packer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Packer, Milton, et al.. (2026). What Exactly Is Cardiometabolic HFpEF: A Phenotype or an Endotype?. Circulation Heart Failure. 19(3). e014031–e014031.

Pabón, Maria, John W. Ostrominski, Brian Claggett, et al.. (2025). PROGNOSTIC IMPACT OF HEPATORENAL DYSFUNCTION AND CARDIOVASCULAR-KIDNEYMETABOLIC MULTIMORBIDITY IN HEART FAILURE: A PARTICIPANT-LEVEL POOLED ANALYSIS OF THE PARADIGM-HF AND PARAGON-HF TRIALS. Journal of the American College of Cardiology. 85(12). 1339–1339.

Gregson, John, Stuart Pocock, Stefan D. Anker, et al.. (2024). Competing Risks in Clinical Trials. Journal of the American College of Cardiology. 84(11). 1025–1037. 2 indexed citations

Matsumoto, Shingo, Rudolf A. de Boer, Felipe A Martinez, et al.. (2024). Beta-blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction. European Heart Journal. 45(Supplement_1). 1 indexed citations

Butt, Jawad H., Jens Jakob Thune, Jens Cosedis Nielsen, et al.. (2024). Anthropometric Measures and Long-Term Mortality in Non-Ischaemic Heart Failure with Reduced Ejection Fraction: Questioning the Obesity Paradox. European Journal of Heart Failure. 27(3). 527–536. 6 indexed citations

Lu, Henri, Brian Claggett, Milton Packer, et al.. (2024). Visit-to-Visit Changes in Heart Rate in Heart Failure: A Pooled Participant-Level Analysis of the PARADIGM-HF and PARAGON-HF Trials. European Journal of Heart Failure. 27(1). 60–68.

Wilcox, Christopher S., Sanjiv J. Shah, Rachael D. Sussman, et al.. (2024). Bladder Symptoms Provoked by Short, Rapid-Acting Loop Diuretics: A Frequent but Often Overlooked Problem. American Journal of Hypertension. 38(2). 100–103.

Mogensen, Ulrik M., Pardeep S. Jhund, Lars Køber, et al.. (2016). Abstract 17986: Is There Really an “Obesity Paradox” in Heart Failure? An Analysis of PARADIGM-HF. Circulation. 2 indexed citations

McLaughlin, Vallerie V., Richard N. Channick, Hossein Ardeschir Ghofrani, et al.. (2015). Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension. European Respiratory Journal. 46(2). 405–413. 159 indexed citations

10.

Uno, Hajime, Brian Claggett, Lü Tian, et al.. (2014). Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis. Journal of Clinical Oncology. 32(22). 2380–2385. 421 indexed citations breakdown →

11.

Santos, Ângela Barreto Santiago, Elisabeth Kraigher‐Krainer, Natalie A. Bello, et al.. (2013). Left ventricular dyssynchrony in patients with heart failure and preserved ejection fraction. European Heart Journal. 35(1). 42–47. 53 indexed citations

12.

Singal, Amit G., Adam C. Yopp, Celette Sugg Skinner, et al.. (2012). Utilization of Hepatocellular Carcinoma Surveillance Among American Patients: A Systematic Review. Journal of General Internal Medicine. 27(7). 861–867. 213 indexed citations

13.

Fowler, Michael B., Montserrat Vera‐Llonch, Gerry Oster, et al.. (2001). Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. Journal of the American College of Cardiology. 37(6). 1692–1699. 53 indexed citations

14.

Packer, Milton & Jay N. Cohn. (1999). Consensus recommendations for the management of chronic heart failure. 280 indexed citations

15.

Rose, Eric A., Alan J. Moskowitz, Milton Packer, et al.. (1999). The REMATCH trial: rationale, design, and end points. The Annals of Thoracic Surgery. 67(3). 723–730. 249 indexed citations

16.

Packer, Milton & Alan B. Miller. (1999). A symposium : can physicians always explain the results of clinical trials ? A case study of amlodipine in heart failure. 1 indexed citations

17.

Packer, Milton. (1998). Comparative effects of low dose versus high-dose lisinopril on survival and major events in chronic heart failure : the Assessment of Treatment with Lisinopril And Survival Study (ATLAS). European Heart Journal. 19. 142. 19 indexed citations

18.

Lipicky, Raymond J. & Milton Packer. (1993). Role of surrogate end points in the evaluation of drugs for heart failure. Journal of the American College of Cardiology. 22(4). A179–A184. 35 indexed citations

19.

Gottlieb, Stephen S., Marrick Kukin, Joshua Penn, et al.. (1993). Sustained hemodynamic response to flosequinan in patients with heart failure receiving angiotensin-converting enzyme inhibitors. Journal of the American College of Cardiology. 22(4). 963–967. 11 indexed citations

20.

Packer, Milton. (1989). Identification of Risk Factors Predisposing to the Development of Functional Renal Insufficiency during Treatment with Converting-Enzyme Inhibitors in Chronic Heart Failure<sup>1</sup>. Cardiology. 76(2). 50–55. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact